🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the platform has taken down problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

After moments of entering one community, a seller posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Inside these groups, posts show black plastic packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to potentially significant medical dangers”.